Adaptive Radiation Therapy Accelerator Provides Multiple Imaging Modalities Protocols
|
By MedImaging International staff writers Posted on 11 Sep 2008 |
A new radiotherapy system is a linear accelerator engineered specifically for adaptive radiation therapy (ART). Unique in design, the system is an integrated imaging and workflow solution that provides a comprehensive range of image-guided and advanced treatment delivery protocols, including in-room computed tomography (CT) imaging capabilities, and a new multileaf collimator, 160 MLC.
Siemens Healthcare (Erlangen, Germany) presented its latest technologies at the 50th annual meeting of the American Association of Physicists in Medicine (AAPM) in Houston, TX, USA, July 27-31, 2008. The system, called Artiste, offers clinicians multiple imaging modalities. From megavoltage (MV) to gold standard, in-room CT imaging, clinicians can select the optimal imaging application for their treatment approach. Siemens MVision Cone Beam Imaging Package provides remarkable soft-tissue contrast, especially in challenging cases, such as imaging prostheses and with large patients. The CTVision CT-on-rails System provides in-room, diagnostic quality imaging; thus opening up opportunities to implement benchmark concepts, such as daily re-planning.
"Artiste's design incorporates an array of proven components that reinforces clinicians' confidence in adapting protocols for each patient,” said Holger Schmidt, chief executive officer, Oncology Care Systems, Siemens Medical Solutions USA, Inc. "With Artiste, IMRT can be delivered within five minutes in most cases.”
For precise patient positioning, the 550 TxT treatment table meets the growing demand for accuracy and stability, while providing the mechanical strength to accommodate a patient weight capacity of up to 250 kg. Recently, Artiste has gone clinical in four of the most prominent cancer centers around the world: MAASTRO Clinic in the Netherlands; German Cancer Research Center (DKFZ; Heidelberg, Germany); St. Vincent's Private Hospital (Sydney, Australia); and Baton Rouge General's Pennington Cancer Center (LA, USA).
Also being demonstrated at the Siemens booth is syngo VSim, a virtual simulation of radiotherapy treatment planning. syngo VSim supports target and critical structure delineation with isocenter localization; accurately models all structures, radiation beams and linear accelerator parameters; and produces high-quality digital reconstructed radiographs (DRRs), multiplanar reconstructions (MPRs), MIPs (million instructions per second), and shaded surface displays to optimize the clinical process.
With a flexible implementation, syngo VSim software can be accessed at the CT acquisition console or at post-processing workstations. The simulation tool also provides motion management solutions, such as multiple triggering device support and four-dimensional (4D) contouring tools. All these advanced applications support the state-of-the-art Sensation Open platform, Siemens leading edge offering for CT simulation.
Syngo TrueD, a Siemens-exclusive multimodality software solution accelerates the cancer management workflow and offers high-quality biological therapy response assessment. Syngo TrueD also enables physicians to efficiently compare patient scans from up to three different time points (e.g., pre- and post-therapy). By automatically registering and displaying positron emission tomography (PET)/CT, single photon emission computed tomography (SPECT)/CT, CT, or magnetic resonance (MR) images from studies acquired at different times, this advanced application assists physicians in making better informed therapy and follow-up decisions.
Further enhancing ease of use for Artiste is Siemens' comprehensive software solution, syngo Suite for Oncology; a workflow platform, providing scalable workspaces that enable clinical team members to access data, patient information, and images as needed. The suite also includes: (1) syngo MultiModality Workplace, which provides multi-modality imaging solutions in one workplace and uses treatment response evaluation application. (2) Syngo RT Oncologist, which provides tailored physician tool sets and integrates cutting-edge 2D/3D IGRT treatment review tools. (The Coherence range of Oncology workspaces are currently being rebranded to syngo Suite for Oncology. Syngo RT Oncologist may be purchased under the Coherence brand name.) (3) Syngo RT Therapist, which employs MVision technology for 3D image-guided automated patient positioning, and adaptive targeting for IGRT operations for image registration and offset calculation.
Morever, exclusively distributed by Siemens will be the ImageGrid Archive Appliance, which supports ever-increasing storage needs for Digital Imaging and Communications in Medicine (DICOM) RT objects and is ideal for storing treatment plans, contours, treatment reports or any other RT specific objects.
Related Links:
Siemens Healthcare
Siemens Healthcare (Erlangen, Germany) presented its latest technologies at the 50th annual meeting of the American Association of Physicists in Medicine (AAPM) in Houston, TX, USA, July 27-31, 2008. The system, called Artiste, offers clinicians multiple imaging modalities. From megavoltage (MV) to gold standard, in-room CT imaging, clinicians can select the optimal imaging application for their treatment approach. Siemens MVision Cone Beam Imaging Package provides remarkable soft-tissue contrast, especially in challenging cases, such as imaging prostheses and with large patients. The CTVision CT-on-rails System provides in-room, diagnostic quality imaging; thus opening up opportunities to implement benchmark concepts, such as daily re-planning.
"Artiste's design incorporates an array of proven components that reinforces clinicians' confidence in adapting protocols for each patient,” said Holger Schmidt, chief executive officer, Oncology Care Systems, Siemens Medical Solutions USA, Inc. "With Artiste, IMRT can be delivered within five minutes in most cases.”
For precise patient positioning, the 550 TxT treatment table meets the growing demand for accuracy and stability, while providing the mechanical strength to accommodate a patient weight capacity of up to 250 kg. Recently, Artiste has gone clinical in four of the most prominent cancer centers around the world: MAASTRO Clinic in the Netherlands; German Cancer Research Center (DKFZ; Heidelberg, Germany); St. Vincent's Private Hospital (Sydney, Australia); and Baton Rouge General's Pennington Cancer Center (LA, USA).
Also being demonstrated at the Siemens booth is syngo VSim, a virtual simulation of radiotherapy treatment planning. syngo VSim supports target and critical structure delineation with isocenter localization; accurately models all structures, radiation beams and linear accelerator parameters; and produces high-quality digital reconstructed radiographs (DRRs), multiplanar reconstructions (MPRs), MIPs (million instructions per second), and shaded surface displays to optimize the clinical process.
With a flexible implementation, syngo VSim software can be accessed at the CT acquisition console or at post-processing workstations. The simulation tool also provides motion management solutions, such as multiple triggering device support and four-dimensional (4D) contouring tools. All these advanced applications support the state-of-the-art Sensation Open platform, Siemens leading edge offering for CT simulation.
Syngo TrueD, a Siemens-exclusive multimodality software solution accelerates the cancer management workflow and offers high-quality biological therapy response assessment. Syngo TrueD also enables physicians to efficiently compare patient scans from up to three different time points (e.g., pre- and post-therapy). By automatically registering and displaying positron emission tomography (PET)/CT, single photon emission computed tomography (SPECT)/CT, CT, or magnetic resonance (MR) images from studies acquired at different times, this advanced application assists physicians in making better informed therapy and follow-up decisions.
Further enhancing ease of use for Artiste is Siemens' comprehensive software solution, syngo Suite for Oncology; a workflow platform, providing scalable workspaces that enable clinical team members to access data, patient information, and images as needed. The suite also includes: (1) syngo MultiModality Workplace, which provides multi-modality imaging solutions in one workplace and uses treatment response evaluation application. (2) Syngo RT Oncologist, which provides tailored physician tool sets and integrates cutting-edge 2D/3D IGRT treatment review tools. (The Coherence range of Oncology workspaces are currently being rebranded to syngo Suite for Oncology. Syngo RT Oncologist may be purchased under the Coherence brand name.) (3) Syngo RT Therapist, which employs MVision technology for 3D image-guided automated patient positioning, and adaptive targeting for IGRT operations for image registration and offset calculation.
Morever, exclusively distributed by Siemens will be the ImageGrid Archive Appliance, which supports ever-increasing storage needs for Digital Imaging and Communications in Medicine (DICOM) RT objects and is ideal for storing treatment plans, contours, treatment reports or any other RT specific objects.
Related Links:
Siemens Healthcare
Latest Radiography News
- Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
- AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
- Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
- AI Detection Tool Improves Identification of Lobular Breast Cancer
- New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
- AI Boosts Breast Cancer Detection and Cuts Screening Workload
- AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
Channels
MRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channel
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read more
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read moreGeneral/Advanced Imaging
view channelNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more
Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
Obesity surgery improves weight and comorbidity profiles, yet clinicians lack tools to monitor organ-level metabolic recovery after the procedure. A clear view of systemic changes could refine follow-up... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







